Taken together, the DOI trajectory for the MTHFR 677 TT variant shows biomarker of sufficient early methylation without any abnormal symptoms, with mid-phase transition to negative symptoms with depression and biomarkers of low methylation. The gene discussed is MTHFR; the disease is depressive symptom measurement.